Key details
Sponsor
Imperial College London
Collaborators
Merck Sharp & Dohme LLC
Enrollment target
~18 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
30 Years – 70 Years
Last updated February 2025